Matthew Faber

Matthew Faber

Company: Xencor

Job title: Senior Scientist, Protein & Antibody Engineering

Seminars:

XmAb541, a Claudin 6-Targeted Bispecific Antibody Therapy for Targeting Solid Tumors 9:30 am

Preclinical development of XmAb541, a CLDN6 x CD3 bispecific antibody for selective targeting of CLDN6 expressing tumorsRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.